Countermeasure development pathways
Stages from discovery to licensure are described with the regulatory decisions at each step, so institutions understand where emergency timelines can and cannot shorten.
GRF · Health and Biosecurity Governance
Molecular and life sciences for health and biosecurity governance
The life sciences supply the knowledge behind countermeasures and the capabilities that biosecurity governs. In this field they are explained so that institutions can judge research oversight, countermeasure pathways and the pace of change in biological tools.
01Register
Key facts.
Method recordSTEM method
- MethodMolecular and life sciences
- Applied inHealth and Biosecurity Governance
- Data4 inputs
- Checks3 validation steps
- Canonical pageSTEM Commons
02Application
What molecular and life sciences does here.
Molecular and life sciences study the structure and function of living systems from genes and proteins to cells and organisms. They underpin the understanding of pathogens, resistance, toxicity and biological innovation. In health and biosecurity, life sciences support pathogen characterisation, antimicrobial resistance tracking and biosecurity assessment. They inform how biological threats might spread through health, agriculture and trade. The canonical description is on the STEM Commons.
Biosafety risk assessment
Laboratory work is assessed by agent, procedure and setting, following WHO's risk-based approach, to choose proportionate controls.
Horizon scanning of biological tools
Developments in synthesis, editing and AI-assisted design are reviewed for governance implications without publishing enabling detail.
03Monitor
Oversight register.
The screen a team would use to follow this method: its measures, states and decisions. Names are examples and values are illustrative.
Oversight register
Health and biosecurity governance · Molecular and life sciences · Run R-7129
Reviews currentGRF · Health and Biosecurity Governance
Institutional reviews
capacity and oversight only
| Project P-619 | Institutional committee | Level 1 | Q2 | Pending |
| Project P-244 | Institutional committee | Level 1 | Q1 | Conditions |
| Project P-887 | Institutional committee | Level 1 | Q1 | Conditions |
| Project P-540 | Institutional committee | Level 1 | Q1 | Conditions |
Training coverage
04Data
What the method consumes.
Datasets and records used by molecular and life sciences on this platform, with the role each plays and the label its values carry. Sources are listed in the source register.
| Data | Role | Label |
|---|---|---|
| Clinical trial registries | Countermeasure pipelines | REPORTED |
| Regulatory approval records | Authorised products | Published statistics |
| Biosafety incident reports | Laboratory risk | REPORTED |
| Scientific literature | Technical developments | REPORTED |
05Decision model
When measures start, and how much they buy.
How the start day and the strength of contact measures change the size and timing of the peak and the share ever infected, the trade-off a public health decision weighs. Teaching model with stated illustrative values, not a prediction.
Controls
- Basic reproduction number R0
- 2.5
- Latent period
- 3.0 days
- Infectious period
- 5.0 days
- Share of contacts made in other places
- 8%
- Places in the network
- 24
- Measures start on day
- 40
- Contact reduction from measures
- 40%
- Days simulated
- 240 days
Readouts
- Peak new infections
- 4.68 per 1,000 a day
- Day of the peak
- 156
- Share ever infected
- 57%
- Places reached
- 100%
- Reproduction number under measures
- 1.50
Numbers, methods and sources
| Day | New infections per 1,000 | Cumulative infected (%) |
|---|---|---|
| 0 | 0.00 | 0.0 |
| 17 | 0.02 | 0.0 |
| 34 | 0.26 | 0.2 |
| 51 | 0.76 | 1.1 |
| 68 | 1.37 | 2.9 |
| 85 | 2.16 | 6.0 |
| 102 | 3.04 | 10.4 |
| 119 | 3.82 | 16.3 |
| 136 | 4.37 | 23.3 |
| 153 | 4.67 | 31.1 |
| 170 | 4.51 | 38.9 |
| 187 | 3.86 | 46.1 |
| 204 | 2.76 | 51.7 |
| 221 | 1.57 | 55.3 |
| 238 | 0.75 | 57.2 |
Methods
- SEIR compartments Kermack and McKendrick (1927), Proc. R. Soc. A 115
- Metapopulation coupling by mobility Balcan and others (2009), PNAS 106
- Small-world network Watts and Strogatz (1998), Nature 393
- Modelling infectious diseases Keeling and Rohani (2008), Princeton University Press
- Uncertainty fan (parameter Monte Carlo) Spiegelhalter, Pearson and Short (2011), Visualising uncertainty about the future, Science 333
- One-at-a-time sensitivity (tornado) Saltelli and others (2008), Global Sensitivity Analysis: The Primer, Wiley
Data
The model runs on the teaching values set by the controls. To calibrate it for a place, read it against these admitted layers and series, which this page's map can draw:
- Cities Natural Earth
- Airports Natural Earth
- Major roads Natural Earth
Across the six pillars, led by Nexus Consortium
- Experiments Labs
- Built in Health and Biosecurity Governance in Foundry
- Tested at Health and Biosecurity Governance in Universe
- Codified in Health and Biosecurity in Standards
- Published in Health and Biosecurity Governance in Reports
- Taught in Faculty of Health and Society in Academy
06Validation
How results are checked.
Results are confirmed through biological replicates, independent laboratories and orthogonal assays. Reference standards and proficiency testing check analytical accuracy.
| Check | How it is done |
|---|---|
| Information hazard review | Material is reviewed so it does not publish details that could enable misuse |
| Regulatory status stated | Product descriptions state their regulatory stage |
| Expert review | Technical summaries are checked by domain experts |
Laboratory findings do not always translate to organisms or populations. Sampling bias in sequence databases limits generalisation.
07Implementation
From mandate to evaluation, by pillar.
The steps an instrument takes from mandate to evaluation, each with the pillar that runs it, and the decisions that stay with the authority. Teaching model with stated illustrative values, not a prediction.
- Mandate and problem framing Competent authority (outside the programme)
A competent authority frames the problem and the mandate under its own rules. Howlett, Ramesh and Perl (2009) - Evidence and system model Foundry
The system is modelled with its feedbacks, data and stated limits. OECD (2014), principle 2 - Options appraised with scenarios Foundry
Instruments are compared under scenarios, with uncertainty shown. Hood (1983) - Exercise with stakeholders Universe
The options are tested in an exercise with those who would implement and bear them. OECD (2014), principle 3 - Standard or guidance drafted Nexus Standards
What works is codified as a standard or guidance, open to comment. Nexus Standards process - Decision by the authority Competent authority (outside the programme)
The authority decides, outside the programme, with the evidence on record. Howlett, Ramesh and Perl (2009) - Capacity and training Risk Academy
Those who implement are trained on the decided instrument and its data. Sendai Framework (2015), priority 2 - Monitoring and public report Reports
Indicators are published with sources, limits and corrections. OECD (2014), principle 5 - Evaluation and revision Nexus Standards
Results return to the standard and the model: the cycle closes. Howlett, Ramesh and Perl (2009)
Methods
- Policy cycle Howlett, Ramesh and Perl (2009), Studying Public Policy, Oxford University Press
- Governance of critical risks OECD (2014), Recommendation of the Council on the Governance of Critical Risks
- Layered drawing of directed graphs Sugiyama, Tagawa and Toda (1981), IEEE SMC 11
Across the six pillars, led by Nexus Consortium
- Experiments Labs
- Built in Health and Biosecurity Governance in Foundry
- Tested at Health and Biosecurity Governance in Universe
- Codified in Health and Biosecurity in Standards
- Published in Health and Biosecurity Governance in Reports
- Taught in Faculty of Health and Society in Academy
09Sector signature
Who a decision on molecular and life sciences for health and biosecurity governance reaches.
The sectors a policy on molecular and life sciences for health and biosecurity governance has to coordinate: a choice in one ministry lands in the others.
Select corners · hover lines6 / 15 relations
Signature
Health and its partners
Health gives workforce for operations to infrastructure (0.3), farm labour to food (0.3) and utility workforce to water (0.2).
W · E · I · F · H · B
- Sectors
- 4 of 6
- Relations
- 6 of 15
- Coupling
- 0.42 share of total
Strongest relations in play
- Water → Food · irrigation0.8
- Food → Health · nutrition0.7
- Infrastructure → Water · pipes, dams and treatment works0.6
- Water → Health · drinking water and sanitation0.7
10Stewardship
Who maintains the method.
Biotechnology and Biosecurity stewards molecular and life sciences for the Consortium and reviews how it is applied across platforms.
11Instruments and commitments
Instruments, mandates and commitments.
The instruments, mandates, actors and accountability arrangements a policymaker, diplomat or development agency works with, citing the agreements that set them. Structures follow the frameworks named. Any state or progress drawn is illustrative, not a record.
Policy instrument matrix
The kinds of instrument available on molecular and life sciences for health and biosecurity governance, by level of government and cooperation.
| Instrument type | Local | National | Regional | Global |
|---|---|---|---|---|
| Regulatory | Zoning, building codes | Laws, standards, licensing | Harmonised rules | Conventions and treaties |
| Economic | Local levies, grants | Budget lines, taxes, insurance schemes | Risk pools, regional funds | Financing mechanisms |
| Information | Local warnings | Disclosure, early warning, statistics | Data sharing arrangements | Global monitoring and reporting |
| Institutional | Local committees | Lead agencies, coordination councils | Regional bodies and secretariats | Multilateral mandates |
| Cooperative | Community agreements | Partnership compacts | Memoranda and joint programmes | Agreements and joint commitments |
Sendai Framework for Disaster Risk Reduction · UNDRRParis Agreement · UNFCCC2030 Agenda and the Sustainable Development Goals · United NationsInternational Health Regulations · WHO
12Connected
Where this page leads across the Consortium.
13Questions
Questions and answers.
What are the limits of molecular and life sciences in this field?
Laboratory findings do not always translate to organisms or populations. Sampling bias in sequence databases limits generalisation.
How are results checked?
Results are confirmed through biological replicates, independent laboratories and orthogonal assays. Reference standards and proficiency testing check analytical accuracy.
Are the values on this page real?
The data names, roles and checks are real descriptions of practice. The canvas shows a design of the method's use, not a run; no result is reported here.
Where else is this method applied?
The canonical method page lists every platform that applies it.
ReportsContribute
Contribute evidence from this page.
Reports is the Consortium's quarterly publication. What you know about this subject can become evidence, a case or a correction in the next edition, credited to you and published under CC BY 4.0 where it is your own work.
Global Risks ForumHealth and Biosecurity GovernanceEvidence Brief
- EmailGateway GW-GRFSend it from this pageEvidence, a correction, a case, a method, a review, a translation or profile input. It arrives tagged with this page, so the editor who owns it receives it.
- ZenodoOpen depositDeposit it and submit to the communityPublish your own record on Zenodo with your ORCID iD, then submit it to the Reports community there. Curators review it; the DOI stays yours.
- ReportsGlobal Risks ForumSee every way to contributeThe contribution types, how each is reviewed, what credit you receive, the licence and what is never accepted.
Never send personal data, sensitive infrastructure detail or anything you have no right to share. A contribution is reviewed before use; sending it confers no authorship or editorial rights, and sponsorship never buys a finding.
Health and Biosecurity Governance
Bring a governance question to the Forum.
Information and enquiries are open today. An enquiry receives a reference and names the next step; applications, payments, compute allocations and registrations open only when their team, terms and review capacity exist.
Legal
Legal documents.
Show all 18 legal documents
Maps, data and figures on this site are shown for context and general information. They are not advice, forecasts or warnings; the limits of the information are set out in the Disclaimers and Data Notices.